Molecular Interactions of New Pregnenedione Derivatives
January 2003
in “
Chemical and Pharmaceutical Bulletin
”
Studysummary This study reports that five new progesterone derivatives demonstrated inhibitory activity against the 5α-reductase enzyme and binding affinity for the androgen receptor in an in vitro hamster model.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study evaluated the in vitro inhibitory activity of five new progesterone derivatives on the 5α-reductase enzyme and their antagonistic effects on the androgen receptor. The compounds showed varying IC50 values for 5α-reductase inhibition, with compound 3 being the most potent (19 nM). The Ki values indicated that compound 4 had the highest affinity for the androgen receptor, followed by compound 5, dihydrotestosterone, compound 2, compound 3, and compound 1. Overall, all five synthesized compounds were effective 5α-reductase inhibitors and exhibited affinity for the androgen receptor in the hamster prostate.